February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla's Energy Unit Emerges as a Growth Catalyst
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Affimed N.V. (AFMD) stock forecast for 2025
Updated: March 4, 2025 (17:56)
Sector: HealthcareThe share price of Affimed N.V. (AFMD) now
50/200 Day Moving Average: $1.141 / $3.45
This figure corresponds to the Average Price over the previous 50/200 days. For Affimed N.V. stocks, the 50-day moving average is the resistance level today.
For Affimed N.V. stocks, the 200-day moving average is the resistance level today.
Are you interested in Affimed N.V. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Affimed N.V. stock price in 2025. How much will one Affimed N.V. share be worth in 2025? Is it worth taking profit / loss on AFMD stock now or waiting? What are analysts' forecasts for Affimed N.V. stock?
We forecast Affimed N.V. stock performance using neural networks based on historical data on AFMD stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Affimed N.V. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Affimed N.V. analysts is $13.45. Today 200 Day Moving Average is the resistance level (3.45 $). 50 Day Moving Average is the resistance level (1.141 $).
Historical and forecast chart of Affimed N.V. stock
The chart below shows the historical price of Affimed N.V. stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AFMD stock price can be found in the table below.
Affimed N.V., a clinical-stage biopharmaceutical company, is engaged in the discovery and development of immunotherapy treatments for cancer in the United States, Europe and Germany. The lead product candidate is AFM13, which has completed a Phase II clinical trial for CD30-positive T-cell lymphoma and Hodgkin’s lymphoma (HL) and is in Phase II clinical trials for peripheral T-cell lymphoma and transformed fungal mycosis.
Affimed N.V. (AFMD) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr | 1.02 | 0.93 | 1.09 | 14.98 % |
| May | 0.97 | 0.88 | 1.02 | 13.87 % |
| Jun | 1.00 | 0.91 | 1.08 | 15.55 % |
| Jul | 0.98 | 0.96 | 1.04 | 8.18 % |
| Aug | 0.97 | 0.95 | 1.00 | 5.14 % |
| Sep | 1.06 | 1.01 | 1.13 | 10.46 % |
| Oct | 1.06 | 0.98 | 1.09 | 10.03 % |
| Nov | 1.12 | 1.07 | 1.17 | 8.40 % |
| Dec | 1.16 | 1.06 | 1.20 | 11.65 % |
Affimed N.V. information and performance
IM NEUENHEIMER FELD 582, 69120, HEIDELBERG, DE
Market capitalization of the Affimed N.V. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AFMD shares in the company outstanding by the market price of one share.
EBITDA of Affimed N.V. is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Affimed N.V. price target for 2025 by month
Target values for the price of one Affimed N.V. share for Apr 2025.
In Apr, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 14.983% volatility is expected.
Pessimistic target level: 0.93
Optimistic target level: 1.09
Target values for the price of one Affimed N.V. share for May 2025.
In May, the Negative dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 13.875% volatility is expected.
Pessimistic target level: 0.88
Optimistic target level: 1.02
Target values for the price of one Affimed N.V. share for Jun 2025.
In Jun, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 15.550% volatility is expected.
Pessimistic target level: 0.91
Optimistic target level: 1.08
Target values for the price of one Affimed N.V. share for Jul 2025.
In Jul, the Negative dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 8.179% volatility is expected.
Pessimistic target level: 0.96
Optimistic target level: 1.04
Target values for the price of one Affimed N.V. share for Aug 2025.
In Aug, the Negative dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 5.138% volatility is expected.
Pessimistic target level: 0.95
Optimistic target level: 1.00
Target values for the price of one Affimed N.V. share for Sep 2025.
In Sep, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 10.457% volatility is expected.
Pessimistic target level: 1.01
Optimistic target level: 1.13
Target values for the price of one Affimed N.V. share for Oct 2025.
In Oct, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 10.031% volatility is expected.
Pessimistic target level: 0.98
Optimistic target level: 1.09
Target values for the price of one Affimed N.V. share for Nov 2025.
In Nov, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 8.397% volatility is expected.
Pessimistic target level: 1.07
Optimistic target level: 1.17
Target values for the price of one Affimed N.V. share for Dec 2025.
In Dec, the Positive dynamics for Affimed N.V. shares will prevail with possible monthly volatility of 11.651% volatility is expected.
Pessimistic target level: 1.06
Optimistic target level: 1.20
Related stocks from Healthcare sector
